Millennium Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-75,000
Closed -$3.61M – 3677
2015
Q2
$3.61M Buy
+75,000
New +$4.38M 0.01% 1582

Other funds holding PTCT

Millennium Management's PTCT Position: Q3 2026 in Review

Millennium Management reduced its PTC Therapeutics (PTCT) stake by 19% in Q3 2026, selling an estimated $649K and leaving 37,580 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

Millennium Management first reported a position in PTCT in Q2 2014 and has held it in 41 quarters since. The position peaked at $64.8M in Q3 2025. 361 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

  • Millennium Management held 37,580 shares of PTC Therapeutics worth $2.43M as of Q3 2026.
  • Millennium Management sold 8,914 PTC Therapeutics shares in Q3 2026, an estimated $649K.
  • PTC Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #3743 holding.
  • Millennium Management first reported a position in PTC Therapeutics in Q2 2014 and has held it in 41 quarters since.
  • Millennium Management's PTC Therapeutics position peaked at $64.8M in Q3 2025.
  • 361 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.